Indeed, TGF‐β is increased significantly in COVID‐19 patients.[43] It is also well known that activation of TGF‐β signaling in TECs can induce AKI,[44] which is blocked by deleting TGF‐βRII and Smad3 (26, 27). Here, SMAD3 is linked to COVID-19.